This analysis explores antimicrobial efficacy and in silico interactions of plant extracts in germicidal applications, suggesting safe alternatives.
Conventional germicidal products often contain hazardous chemicals that pose risks to human health and the environment and can contribute to the development of resistance. Plant bioactive compounds offer a greener alternative. Although there are numerous studies on the antibacterial activity of plant extracts, research on in silico analysis of plant bioactive compounds targeting bacterial proteins is less common. This research aimed to explore the antimicrobial potential of Salvia rosmarinus and Hibiscus rosa sinensis x L. through both in vitro and in silico analysis for integration into germicidal products. Both samples displayed promising antibacterial properties. Among the identified bioactive compounds, Tricyclo[20.8.0.0(7,16)]triacontane,1(22),7(16)-diepoxy from rosemary, and 1,3-Diphenyl-1,2-butanediol from hibiscus exhibited the strongest negative binding energies against target proteins. Tricyclo[20.8.0.0(7,16)] triacontane,1(22),7(16)-diepoxy achieved a docking score of -11 kcal/mol against S.aureus protein, while 1,3-Diphenyl-1,2-butanediol scored − 7.5 kcal/mol against K. pneumoniae protein. Both in vitro and in silico findings confirm the significant antimicrobial activity of rosemary and hibiscus extracts due to their bioactive compounds, indicating their promise for inclusion in germicidal products.
No takes yet. Share an insight, caveat, or question.
Shedge et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: